Consensus CureVac N.V.

Equities

CVAC

NL0015436031

Market Closed - Nasdaq 04:00:00 2024-06-20 pm EDT 5-day change 1st Jan Change
3.26 USD +0.31% Intraday chart for CureVac N.V. -18.50% -22.57%

Evolution of the average Target Price on CureVac N.V.

Price target over the last 5 years

History of analyst recommendation changes

4e63fcd3e980a5c32628e690bd.mb5rzqfdzgF8NwT8237t7dzRAG81X0Eo9oKb1Jqzf9I.y_YviuCHg1c5eUrEo0i3iaW2cApgMgh3m8rpi_yHGJj05D-9zK2XXk0Daw~50c424ecaa8ccc99ce4898f602e1d1ba
CUREVAC : Significant cash drain in the Q1 Alphavalue
CUREVAC : A missed opportunity Alphavalue
UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating MT
Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 MT
Kempen Upgrades CureVac to Buy From Neutral, Price Target is $10 MT
CUREVAC : An untrimmed pipeline becomes costly Alphavalue
CUREVAC : Unchanged cash drain Alphavalue
CUREVAC : A missed opportunity Alphavalue
CUREVAC : Higher losses expected in future Alphavalue
CUREVAC : Some glimpse of positive pipeline developments Alphavalue
SVB Securities Initiates CureVac at Outperform With $13 Price Target MT
CUREVAC : Runway prolonged Alphavalue
CUREVAC : One big point despite many misses Alphavalue
JMP Securities Adjusts Price Target on CureVac to $24 From $34, Maintains Outperform Rating MT
CUREVAC : Everything hangs on the decision of the new CEO Alphavalue
UBS Upgrades CureVac to Buy From Neutral, Adjusts Price Target to $18 From $8 MT
CUREVAC : UBS raises its recommendation to Buy ZD
Health Care Down Sharply on Rate-Sensitive Sector Bias -- Health Care Roundup DJ
Jefferies Upgrades CureVac to Buy From Hold MT
CUREVAC : Berenberg reaffirms its Buy rating ZD
UBS Initiates Coverage on CureVac With Neutral Rating, $8 Price Target MT
JMP Securities Adjusts Price Target on CureVac to $34 From $37, Maintains Market Outperform Rating MT
Berenberg Bank Adjusts CureVac Price Target to $22 From $45, Maintains Buy Rating MT
Roche’s Alzheimer’s failure has sector-wide implications Alphavalue
Berenberg US CEO Conference FA
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
3.042 EUR
Average target price
8.728 EUR
Spread / Average Target
+186.89%
High Price Target
16.61 EUR
Spread / Highest target
+446.05%
Low Price Target
2.391 EUR
Spread / Lowest Target
-21.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CureVac N.V.

alphavalue Martin Schnee
UBS
Leerink Partners
Kempen
SVB Securities LLC
JMP Securities
Jefferies & Co.
BERENBERG Zhiqiang Shu
Berenberg Bank
BofA Securities
Deutsche Bank Securities
Guggenheim
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
  1. Stock Market
  2. Equities
  3. CVAC Stock
  4. Consensus CureVac N.V.